OPENING OF BANKRUPTCY

UNIVERCELLS

Export PDF

Financial year 2023 · closed on 31/12/2023

Net result

20,4 M €

+402.8% YoY

Equity

142,8 M €

+30.8% YoY

Workforce

83,6 ETP

-4.3% YoY

Company — Opening of bankruptcy.

What does UNIVERCELLS do?

UNIVERCELLS is a Public limited company incorporated in 2013. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Charleroi. It employs on average 83,6 ETP workers (FTE).

Legal situation

● Opening of bankruptcy

BCE/KBO no. / VAT

BE 0502.742.288

Incorporation

24/01/2013

Legal form

Public limited company

Registered office

Zoning de Jumet,avenue Centrale 52
6040 Charleroi · Wallonie

Contributed capital

115 273 638,01 €

Latest accounts

31/12/2023

Average workforce

83,6 ETP

Activities (NACE)

21209Manufacture of pharmaceutical preparations· main 21209Manufacture of pharmaceutical preparations

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 8 financial years

	2023		2022		2021		2017		2016		2015		2014		2013
Income statement
Revenue	–		–		–		922,6 k €	-0.6%	928,6 k €	+8.6%	854,8 k €	+373%	180,9 k €	+5928%	3 k €
EBITDA	-5 M €	+41.4%	-8,5 M €	-22.8%	-6,9 M €	-125%	-3,1 M €	-196%	-1 M €	-165%	-392,3 k €	-106%	-190,1 k €	+47.6%	-362,6 k €
Operating result	-10 M €	+17.0%	-12 M €	-63.6%	-7,3 M €	-77.9%	-4,1 M €	-126%	-1,8 M €	-75.0%	-1 M €	-349%	-231,8 k €	+40.2%	-387,6 k €
Net result	20,4 M €	+403%	-6,8 M €	+18.7%	-8,3 M €	-131%	-3,6 M €	-94.8%	-1,8 M €	-77.8%	-1 M €	-354%	-228,6 k €	+41.0%	-387,7 k €
Balance sheet
Equity	142,8 M €	+30.8%	109,2 M €	+52.5%	71,6 M €	+4712%	1,5 M €	+358%	-576 k €	-142%	1,4 M €	+1016%	-150,3 k €	-341%	62,3 k €
Total assets	231,6 M €	+21.7%	190,3 M €	+35.2%	140,7 M €	+1083%	11,9 M €	-14.0%	13,8 M €	+413%	2,7 M €	+405%	533,3 k €	+186%	186,7 k €
Cash	3,3 M €	-51.1%	6,7 M €	-52.6%	14,2 M €	+631%	1,9 M €	-37.8%	3,1 M €	+530%	496 k €	+2189%	21,7 k €	-58.7%	52,4 k €
Debts	87,5 M €	+9.4%	80 M €	+16.5%	68,7 M €	+2377%	2,8 M €	+4.4%	2,7 M €	+108%	1,3 M €	+86.5%	683,6 k €	+450%	124,4 k €
Other
Workforce	83,6 ETP	-4.3%	87,4 ETP	+41.0%	62,0 ETP	+89.6%	32,7 ETP	+170%	12,1 ETP	+218%	3,8 ETP		–		–

Governance

Board of directors

Seen on filing of 31/12/2023 · 8 active · 7 ended

Active mandates

TIMOTHY E. MORRIS

Director · since 08 février 2022 · until 08 février 2028

Active

ANDRIN OSWALD

Director · since 21 août 2020 · until 18 juin 2026

Active

CELINE VAESSEN

Director · since 21 août 2020 · until 18 juin 2026

Active

DOUGLAS NEUGOLD

Chairman of the board of directors · since 21 août 2020 · until 18 juin 2026

Active

GLENN ROCKMAN

Director · since 21 août 2020 · until 18 juin 2026

Active

HUGUES BULTOT

Managing director · since 21 août 2020 · until 18 juin 2026

Active

JOSE ANTONIO CASTILLO

Director · since 21 août 2020 · until 18 juin 2026

Active

PIERRE-ARMAND MORGON

Director · since 21 août 2020 · until 18 juin 2026

Active

Ended mandates

DOUGLAS NEUGOLD

Director · since 03 avril 2017 · until 02 avril 2023

Ended

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises

Auditor · since 27 juillet 2016 · until 26 juillet 2019 · 0429.053.863

Represented by Julie Delforge

Ended

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises

Auditor · since 30 septembre 2014 · until 15 juin 2017 · 0429.053.863

Represented by Julie Delforge

Ended

GUILLAUME de VIRON

Director · since 24 janvier 2013 · until 20 juin 2019

Ended

At this address

Other companies at this address

Company	CBE no.
EXOTHERA● Bankrupt	0744.643.660
UNIZIMA● Bankrupt	0744.643.759

Annual accounts

Full financial information

	2023	2022	2021	2020	2019	2018
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018
Closing of the financial year	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/07/2024	11/07/2023	22/07/2022	22/06/2021	24/06/2020	10/07/2019
General meeting	28/06/2024	30/06/2023	30/06/2022	17/06/2021	18/06/2020	20/06/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

11 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2023	28/06/2024	11/07/2024	French	PDF
Full model	31/12/2022	30/06/2023	11/07/2023	French	PDF
Full model	31/12/2021	30/06/2022	22/07/2022	French	PDF
Full model	31/12/2020	17/06/2021	22/06/2021	French	PDF
Full model	31/12/2019	18/06/2020	24/06/2020	French	PDF
Full model	31/12/2018	20/06/2019	10/07/2019	French	PDF
Full model	31/12/2017	21/06/2018	13/08/2018	French	PDF
Full model	31/12/2016	10/07/2017	29/08/2017	French	PDF
Full model	31/12/2015	27/07/2016	03/08/2016	French	PDF
Full model	31/12/2014	18/06/2015	11/08/2015	French	PDF
Full model	31/12/2013	30/09/2014	30/09/2014	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2023 · 8 active · 7 ended

Active mandates

TIMOTHY E. MORRIS

Director · since 08 février 2022 · until 08 février 2028

Active

ANDRIN OSWALD

Director · since 21 août 2020 · until 18 juin 2026

Active

CELINE VAESSEN

Director · since 21 août 2020 · until 18 juin 2026

Active

DOUGLAS NEUGOLD

Chairman of the board of directors · since 21 août 2020 · until 18 juin 2026

Active

GLENN ROCKMAN

Director · since 21 août 2020 · until 18 juin 2026

Active

HUGUES BULTOT

Managing director · since 21 août 2020 · until 18 juin 2026

Active

JOSE ANTONIO CASTILLO

Director · since 21 août 2020 · until 18 juin 2026

Active

PIERRE-ARMAND MORGON

Director · since 21 août 2020 · until 18 juin 2026

Active

Ended mandates

DOUGLAS NEUGOLD

Director · since 03 avril 2017 · until 02 avril 2023

Ended

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises

Auditor · since 27 juillet 2016 · until 26 juillet 2019 · 0429.053.863

Represented by Julie Delforge

Ended

Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises

Auditor · since 30 septembre 2014 · until 15 juin 2017 · 0429.053.863

Represented by Julie Delforge

Ended

GUILLAUME de VIRON

Director · since 24 janvier 2013 · until 20 juin 2019

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring19/11/2024
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates12/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates29/08/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares29/06/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates21/04/2023
DEMISSIONS, NOMINATIONS
PDF
Other25/01/2023
DIVERS
PDF
Capital / shares11/01/2023
CAPITAL, ACTIONS
PDF
Capital / shares17/10/2022
CAPITAL, ACTIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

28/10/2024
nominationJulian Peat — administrateur ("Investor Director ")
28/06/2024
nominationLabeeb Abboud — administrateur de la série D
2023
Annual accounts 202320,4 M €↑
2022
Annual accounts 2022-6,8 M €↑
22/12/2022
augmentation_capitalHugues BULTOT
22/12/2022
augmentation_capitalJose CASTILLO
22/12/2022
augmentation_capitalMathias GARNY
22/12/2022
augmentation_capitalDavid LOUVET
22/12/2022
augmentation_capitalVincent VANDERBORGHT
22/12/2022
augmentation_capitalPierre MORGON
22/12/2022
augmentation_capitalDouglas NEUGOLD
22/12/2022
augmentation_capitalDavid SHOFI
30/06/2022
reconductionDeloitte Reviseurs d'Entreprises — commissaire
27/06/2022
augmentation_capitalDoug NEUGOLD
27/06/2022
augmentation_capitalPierre-Armand MORGON
2021
Annual accounts 2021-8,3 M €↓
2017
Annual accounts 2017-3,6 M €↓
2016
Annual accounts 2016-1,8 M €↓
2015
Annual accounts 2015-1 M €↓
2014
Annual accounts 2014-228,6 k €↑
2013
Annual accounts 2013-387,7 k €
24/01/2013
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

UNIVERCELLS

Overview

What does UNIVERCELLS do?

Trend over 8 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline